JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

491 * ! Wed, 8/1/2012, 10:30 AM - 12:20 PM CC-Room 25C
Challenges in Biomarker and Surrogate Endpoint Qualification — Topic Contributed Papers
Biopharmaceutical Section , International Indian Statistical Association
Organizer(s): Qunming Dong, Vertex Pharmaceuticals
Chair(s): Qunming Dong, Vertex Pharmaceuticals
10:35 AM Statistical Evaluation of Surrogate Endpoints: Validity, Efficiency, and Sensitivity Pandurang Kulkarni, Eli Lilly and Company ; Yongming Qu, Eli Lilly and Company ; Wen Li, Singapore Clinical Research Institute
10:55 AM Biomarker Qualification: FDA Experience Aloka Chakravarty, FDA/CDER
11:15 AM Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials Ying Huang, Fred Hutchinson Cancer Research Center ; Peter B Gilbert, University of Washington/Fred Hutchinson Cancer Research Center
11:35 AM Related Causal Frameworks for Surrogate Outcomes in Randomized Trials, with Extensions to Observational Studies and Beyond Marshall Joffe, University of Pennsylvania
12:15 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.